Marc d'Abbadie

Direktör/Styrelseledamot på

Spark Nw Carry Partner LLP

Health Technology

Health Services

Consumer Services

Profil

Dr. Marc d'Abbadie is an Investment Director at SPARK Impact Ltd. He is on the Board of Directors at Dadu Investments Ltd., Nwf4b Directors Ltd., Spark Nw Carry Partner LLP and Videregen Ltd. Dr. d'Abbadie was previously employed as a Non-Executive Director by Evgen Pharma Plc, a Non-Executive Director by Evgen Ltd., a Non-Executive Director by Absynth Biologics Ltd., a Non-Executive Director by EnXray Ltd., a Consultant by McKinsey & Co., Inc., and a Non-Executive Director by Zilico Ltd. He received his graduate degree from Trinity College, Cambridge and a doctorate degree from the University of Cambridge.

Aktiva positioner av Marc d'Abbadie

Företag	Position	Start
SPARK Impact Ltd. SPARK Impact Ltd. Investment ManagersFinance SPARK Impact invests in companies located in the United Kingdom. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, diagnostics, clinical research, analytical services & sciences, healthcare technologies and medical devices. It provides financing for early and growth stage capital requirements.	Privat kapitalinvesterare	-
Videregen Ltd. Videregen Ltd. BiotechnologyHealth Technology Operates a regenerative medicine company created to address the chronic shortage of organs for transplantation	Direktör/Styrelseledamot	-
Spark Nw Carry Partner LLP	Direktör/Styrelseledamot	-
Nwf4b Directors Ltd.	Direktör/Styrelseledamot	-
Dadu Investments Ltd.	Direktör/Styrelseledamot	-

Alla aktiva positioner av Marc d'Abbadie

Tidigare kända positioner av Marc d'Abbadie

Företag	Position	Slut
THERACRYF PLC	Direktör/Styrelseledamot	2018-11-08
EnXray Ltd. EnXray Ltd. Information Technology ServicesTechnology Services Develops sterilization technology solutions for medical device manufacturing companies	Direktör/Styrelseledamot	-
Absynth Biologics Ltd. Absynth Biologics Ltd. BiotechnologyHealth Technology Develops and manufactures immunological prophylaxis, novel vaccines and therapies	Direktör/Styrelseledamot	-
Zilico Ltd. Zilico Ltd. BiotechnologyHealth Technology Develops a medical device to detect cervical cancer and pre-cancerous cells in the cervix	Direktör/Styrelseledamot	-
░░░░░░░░ ░░░░░ ░░░░ ░░░░	░░░░░░░░░░░░░░░░░░░░░░░░░	-

Se detaljerna i Marc d'Abbadies erfarenhet

Marc d'Abbadies utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Marc d'Abbadies erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	13
Evgen Pharma Plc Evgen Pharma Plc Medical/Nursing ServicesHealth Services Engages in the development of pharmaceutical products and focus on cancer & neurological disease	Health Services
McKinsey & Co., Inc. McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm	Commercial Services
University of Cambridge University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Trinity College, Cambridge Trinity College, Cambridge Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Absynth Biologics Ltd. Absynth Biologics Ltd. BiotechnologyHealth Technology Develops and manufactures immunological prophylaxis, novel vaccines and therapies	Health Technology
Zilico Ltd. Zilico Ltd. BiotechnologyHealth Technology Develops a medical device to detect cervical cancer and pre-cancerous cells in the cervix	Health Technology
Evgen Ltd. Evgen Ltd. Medical/Nursing ServicesHealth Services Develops novel glucosinolate based products for the prevention and treatment of human disease	Health Services
SPARK Impact Ltd. SPARK Impact Ltd. Investment ManagersFinance SPARK Impact invests in companies located in the United Kingdom. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, diagnostics, clinical research, analytical services & sciences, healthcare technologies and medical devices. It provides financing for early and growth stage capital requirements.	Finance
Videregen Ltd. Videregen Ltd. BiotechnologyHealth Technology Operates a regenerative medicine company created to address the chronic shortage of organs for transplantation	Health Technology
Spark Nw Carry Partner LLP
Nwf4b Directors Ltd.
Dadu Investments Ltd.
EnXray Ltd. EnXray Ltd. Information Technology ServicesTechnology Services Develops sterilization technology solutions for medical device manufacturing companies	Technology Services